Assertio Holdings Share Holder Equity 2012-2025 | ASRT

Assertio Holdings share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Assertio Holdings Annual Share Holder Equity (Millions of US $)
2024	$121
2023	$138
2022	$226
2021	$102
2020	$56
2019	$58
2018	$220
2017	$170
2016	$251
2015	$315
2014	$364
2013	$137
2012	$84
2011	$106

Assertio Holdings Quarterly Share Holder Equity (Millions of US $)
2025-09-30	$106
2025-06-30	$93
2025-03-31	$109
2024-12-31	$121
2024-09-30	$131
2024-06-30	$132
2024-03-31	$134
2023-12-31	$138
2023-09-30	$193
2023-06-30	$254
2023-03-31	$251
2022-12-31	$226
2022-09-30	$135
2022-06-30	$128
2022-03-31	$112
2021-12-31	$102
2021-09-30	$97
2021-06-30	$92
2021-03-31	$105
2020-12-31	$56
2020-09-30	$76
2020-06-30	$85
2020-03-31	$84
2019-12-31	$58
2019-09-30	$248
2019-06-30	$197
2019-03-31	$209
2018-12-31	$220
2018-09-30	$242
2018-06-30	$191
2018-03-31	$206
2017-12-31	$170
2017-09-30	$199
2017-06-30	$211
2017-03-31	$230
2016-12-31	$251
2016-09-30	$291
2016-06-30	$297
2016-03-31	$300
2015-12-31	$315
2015-09-30	$342
2015-06-30	$346
2015-03-31	$360
2014-12-31	$364
2014-09-30	$263
2014-06-30	$179
2014-03-31	$160
2013-12-31	$137
2013-09-30	$92
2013-06-30	$83
2013-03-31	$80
2012-12-31	$84
2012-09-30	$86
2012-06-30	$85
2012-03-31	$99
2011-12-31	$106
2011-09-30	$118
2011-06-30	$126
2011-03-31	$125

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.074B	$0.125B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$86.784B	32.96
Zoetis (ZTS)	United States	$55.122B	19.73
Takeda Pharmaceutical (TAK)	Japan	$51.166B	10.44
Daiichi Sankyo, - (DSNKY)	Japan	$38.417B	19.13
BeOne Medicines - (ONC)	Switzerland	$37.465B	198.63
Sandoz Group AG (SDZNY)	Switzerland	$34.412B	0.00
United Therapeutics (UTHR)	United States	$20.227B	17.80
Merck (MKKGY)	Germany	$18.999B	11.71
Shionogi (SGIOY)	Japan	$15.585B	14.31
Neurocrine Biosciences (NBIX)	United States	$13.501B	32.40
IPSEN (IPSEY)	France	$13.099B	0.00
Summit Therapeutics (SMMT)	United States	$12.994B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.867B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.287B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.190B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Grifols, S.A (GRFS)	Spain	$6.202B	0.00
Stevanato Group S.p.A (STVN)	Italy	$5.887B	32.95
Crinetics Pharmaceuticals (CRNX)	United States	$5.258B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.547B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.310B	20.46
Indivior (INDV)	United States	$4.123B	16.83
NewAmsterdam Pharma (NAMS)	Netherlands	$3.848B	0.00
Corcept Therapeutics (CORT)	United States	$3.819B	41.26
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.123B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.966B	9.46
Hypermarcas (HYPMY)	Brazil	$2.906B	19.95
Dyne Therapeutics (DYN)	United States	$2.499B	0.00
Ocular Therapeutix (OCUL)	United States	$2.433B	0.00
Soleno Therapeutics (SLNO)	United States	$2.340B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.101B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.949B	23.09
Ardelyx (ARDX)	United States	$1.941B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.858B	35.79
Amylyx Pharmaceuticals (AMLX)	United States	$1.858B	0.00
Harrow (HROW)	United States	$1.745B	107.09
Oruka Therapeutics (ORKA)	United States	$1.668B	0.00
Enliven Therapeutics (ELVN)	United States	$1.615B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.486B	7.36
BioCryst Pharmaceuticals (BCRX)	United States	$1.416B	84.00
Relay Therapeutics (RLAY)	United States	$1.307B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.264B	0.00
Savara (SVRA)	United States	$1.259B	0.00
Evotec AG (EVO)	Germany	$1.243B	0.00
Aktis Oncology (AKTS)	United States	$1.033B	0.00
Theravance Biopharma (TBPH)	United States	$1.032B	43.34
ARS Pharmaceuticals (SPRY)	United States	$1.032B	0.00
Cronos Group (CRON)	Canada	$0.996B	0.00
Xencor (XNCR)	United States	$0.928B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.864B	20.42
KalVista Pharmaceuticals (KALV)	United States	$0.804B	0.00
Nektar Therapeutics (NKTR)	United States	$0.751B	0.00
Esperion Therapeutics (ESPR)	United States	$0.712B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.683B	6.10
Bioventus (BVS)	United States	$0.662B	13.56
ProKidney (PROK)	United States	$0.647B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.528B	0.00
Lyell Immunopharma (LYEL)	United States	$0.512B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.508B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.506B	0.00
Organogenesis (ORGO)	United States	$0.487B	0.00
Altimmune (ALT)	United States	$0.482B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.479B	0.00
Siga Technologies (SIGA)	United States	$0.477B	6.53
4D Molecular Therapeutics (FDMT)	United States	$0.439B	0.00
Nature's Sunshine Products (NATR)	United States	$0.424B	25.24
Aquestive Therapeutics (AQST)	United States	$0.410B	0.00
USANA Health Sciences (USNA)	United States	$0.407B	11.35
Cybin (HELP)	Canada	$0.377B	0.00
Akebia Therapeutics (AKBA)	United States	$0.364B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.300B	0.00
Protara Therapeutics (TARA)	United States	$0.298B	0.00
Avalo Therapeutics (AVTX)	United States	$0.292B	0.00
Profound Medical (PROF)	Canada	$0.290B	0.00
OmniAb (OABI)	United States	$0.289B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.289B	0.00
Relmada Therapeutics (RLMD)	United States	$0.279B	0.00
Larimar Therapeutics (LRMR)	United States	$0.275B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.268B	0.00
Heron Therapeutics (HRTX)	United States	$0.268B	0.00
Fractyl Health (GUTS)	United States	$0.254B	0.00
Journey Medical (DERM)	United States	$0.241B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.233B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.221B	0.00
MediWound (MDWD)	Israel	$0.219B	0.00
Galectin Therapeutics (GALT)	United States	$0.204B	0.00
AleAnna (ANNA)	United States	$0.189B	0.00
Minerva Neurosciences (NERV)	United States	$0.181B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.178B	0.00
Surrozen (SRZN)	United States	$0.164B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.159B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.152B	0.00
Context Therapeutics (CNTX)	United States	$0.151B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.142B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.132B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.124B	0.00
Incannex Healthcare (IXHL)	Australia	$0.123B	0.00
Avita Medical (RCEL)	United States	$0.119B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.116B	0.00
Prelude Therapeutics (PRLD)	United States	$0.114B	0.00
Vivani Medical (VANI)	United States	$0.110B	0.00
Cassava Sciences (SAVA)	United States	$0.105B	0.00
Pyxis Oncology (PYXS)	United States	$0.103B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.102B	0.00
Champions Oncology (CSBR)	United States	$0.098B	41.71
Korro Bio (KRRO)	United States	$0.089B	0.00
Gain Therapeutics (GANX)	United States	$0.076B	0.00
PolyPid (PYPD)	Israel	$0.073B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.067B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.066B	0.00
Dominari Holdings (DOMH)	United States	$0.066B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.066B	54.75
Rafael Holdings (RFL)	United States	$0.062B	0.00
Metagenomi Therapeutics (MGX)	United States	$0.061B	0.00
ElectroCore (ECOR)	United States	$0.061B	0.00
Arch Biopartners (ACHFF)	Canada	$0.060B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.056B	0.00
Nutriband (NTRB)	United States	$0.054B	0.00
Lipocine (LPCN)	United States	$0.054B	0.00
Lite Strategy (LITS)	United States	$0.049B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.045B	0.00
Plus Therapeutics (PSTV)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.038B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.037B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.032B	0.00
TherapeuticsMD (TXMD)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
Natural Alternatives (NAII)	United States	$0.027B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Traws Pharma (TRAW)	United States	$0.019B	0.02
Liminatus Pharma (LIMN)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Inotiv (NOTV)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.017B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.017B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.011B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Mangoceuticals (MGRX)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00